Episode Details
Back to Episodes
Podcast: Teva Seeks Label Change for Azilect
Published 14 years, 4 months ago
Description
This fall, The FDA recommended that Teva Neuroscience’s drug rasagiline, brand name Azilect, should not be granted status “to slow the clinical progression of PD.”
Mentioned in this episode:
Researchers are studying the link between sense of smell and brain health. People with and without Parkinson's can help by taking a scratch-and-sniff test. It’s free, mailed to your home and takes just 15 minutes to complete. mysmelltest.org/getstarted